The convergent cancer evolution toward a single cellular destination

Molecular Biology and Evolution

Volumn 33, Issue 1, 2016, Pages 4-12

  Chen, Han ^a   He, Xionglei ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF DEFENSE TECHNOLOGY   (China)

Author keywords

Cancer evolution; Convergence; Expression profile

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CANCER TISSUE; CELL FUNCTION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; CONVERGENT EVOLUTION; EMBRYONIC STEM CELL; FUNCTIONAL STATUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR GENETICS; ONCOGENE; SOLID TUMOR; TUMOR GENE; TUMOR GROWTH; BIOLOGICAL MODEL; GENE EXPRESSION PROFILING; GENETICS; MOLECULAR EVOLUTION; NEOPLASM; ONCOGENESIS AND MALIGNANT TRANSFORMATION;

TRANSCRIPTOME;

EVOLUTION, MOLECULAR; GENE EXPRESSION PROFILING; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC PROCESSES; TRANSCRIPTOME;

EID: 84964756587     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msv212     Document Type: Article

References (52)

1. Adler AS, et al. 2006. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet. 38:421-430.
2. Arumugam M, et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174-180.
3. Beck B, Blanpain C. 2013. Unravelling cancer stem cell potential. Nat Rev Cancer. 13:727-738.
4. Ben-Porath I, et al. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 40:499-507.
5. Bernards R, Weinberg RA. 2002. A progression puzzle. Nature 418:823.
6. Chen H, Lin F, Xing K, He X. 2015. The reverse evolution from multicellularity to unicellularity during carcinogenesis. Nat Commun. 6:6367.
7. Chi JT, et al. 2006. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 3:e47.
8. Davies PC, Lineweaver CH. 2011. Cancer tumors as Metazoa 1.0: Tapping genes of ancient ancestors. Phys Biol. 8:015001.
9. Endres DM, Schindelin JE. 2003. A new metric for probability distributions. IEE EXplore 49:1858-1860.
10. Fan C, et al. 2006. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 355:560-569.
11. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
12. Friedl P, Alexander S. 2011. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992-1009.
13. Garraway LA, Lander ES. 2013. Lessons from the cancer genome. Cell 153:17-37.
14. Gautier L, Cope L, Bolstad BM, Irizarry RA. 2004. Affy- Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307-315.
15. Greaves M, Maley CC. 2012. Clonal evolution in cancer. Nature 481: 306-313.
16. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-674.
17. Hu J, et al. 2013. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol. 31:522-529.
18. Huang S. 2012. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution. Prog Biophys Mol Biol. 110:69-86.
19. Ishizawa K, et al. 2010. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7:279-282.
20. Kim J, et al. 2010. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143:313-324.
21. Kim J, Orkin SH. 2011. Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine. Genome Med. 3:75.
22. Kullback S, Leibler R. 1951. On information and sufficiency. Ann Math Stat. 22:79-86.
23. Lu Y, et al. 2007. Common human cancer genes discovered by integrated gene-expression analysis. PLoS One 2:e1149.
24. Malumbres M, Barbacid M. 2009. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153-166.
25. Massague J. 2007. Sorting out breast-cancer gene signatures. N Engl J Med. 356:294-297.
26. Matsui W, et al. 2004. Characterization of clonogenic multiple myeloma cells. Blood 103:2332-2336.
27. Mayr E. 1972. Lamarck revisited. J Hist Biol. 5:55-94.
28. Mizuno H, Spike BT, Wahl GM, Levine AJ. 2010. Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A. 107:22745-22750.
29. Nguyen DX, Bos PD, Massague J. 2009. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 9:274-284.
30. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
31. Ostrow SL, Barshir R, DeGregori J, Yeger-Lotem E, Hershberg R. 2014. Cancer evolution is associated with pervasive positive selection on globally expressed genes. PLoS Genet. 10:e1004239.
32. Ramaswamy S, et al. 2001. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 98:15149- 15154.
33. Ramaswamy S, Ross KN, Lander ES, Golub TR. 2003. A molecular signature of metastasis in primary solid tumors. Nat Genet. 33:49-54.
34. Rhodes DR, Chinnaiyan AM. 2005. Integrative analysis of the cancer transcriptome. Nat Genet. 37(Suppl):S31-S37.
35. Rhodes DR, et al. 2004. Large-scale meta- Analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A. 101:9309-9314.
36. Sandberg R, Larsson O. 2007. Improved precision and accuracy for microarrays using updated probe set definitions. BMC Bioinformatics 8:48.
37. Schug J, et al. 2005. Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol. 6:R33.
38. Shannon CE. 1997. The mathematical theory of communication. 1963. MD Comput. 14:306-317.
39. Shats I, et al. 2011. Using a stem cell-based signature to guide therapeutic selection in cancer. Cancer Res. 71:1772-1780.
40. Sobin LH, Fleming ID. 1997. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80:1803-1804.
41. Subramanian A, et al. 2005. Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 102:15545-15550.
42. Takebe N, Ivy SP. 2010. Controversies in cancer stem cells: Targeting embryonic signaling pathways. Clin Cancer Res. 16:3106-3112.
43. Taube JH, et al. 2010. Core epithelial- To-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A. 107:15449-15454.
44. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 98:5116-5121.
45. Valastyan S, Weinberg RA. 2011. Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275-292.
46. van de Vijver, MJ, et al. 2002. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347:1999-2009.
47. Vander Heiden, MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033.
48. Wang X, et al. 2009. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461:495-500.
49. Wang Y, et al. 2005. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671-679.
50. Weinberg RA. 2014. Coming full circle-from endless complexity to simplicity and back again. Cell 157:267-271.
51. Wong DJ, et al. 2008. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2:333-344.
52. Yuan Y, et al. 2014. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol. 32:644-652.